OBJECTIVE: To investigate whether patient-reported symptoms provide independent prognostic information for survival in patients with hematological malignancies. STUDY DESIGN AND SETTING: Overall 119 patients with various diagnoses were recruited in an observational study and symptoms were assessed with the M.D. Anderson Symptom Inventory (MDASI). Key potential socio-demographic, biomedical, and physician-reported prognostic candidates were also considered. The Cox proportional hazards regression model was used for both univariate and multivariate analyses of survival. Additional sensitivity analysis, based on 500 bootstrap-generated simulation datasets, was also performed to confirm the results obtained with the Cox regression model. RESULTS: The median survival of the entire cohort was 4.8 months (range 0-28 months). The MDASI was completed at baseline by 91% of patients. The final multivariate model retained two parameters as independent prognostic factors for survival: clinical prognostic group and patient's self-reported severity of drowsiness. The following hazard ratios (HR) were found for curable vs. terminal: 0.055 (95% CI, 0.022-0.136; P < 0.001) and 0.193 (95% CI, 0.103-0.362: P < 0.001) for advanced vs. terminal. Patient's self-reported severity of drowsiness independently predicted survival with a HR of 1.801 (95% CI, 1.044-3.107; P = 0.033). Additional sensitivity analysis confirmed the independent prognostic value of variables identified in this study. CONCLUSION: The results suggest that patients' self-reporting of symptoms provides independent prognostic information for survival in patients with hematologic malignancies. These findings underscore the value of collecting patient-reported symptom data in routine clinical practice.
OBJECTIVE: To investigate whether patient-reported symptoms provide independent prognostic information for survival in patients with hematological malignancies. STUDY DESIGN AND SETTING: Overall 119 patients with various diagnoses were recruited in an observational study and symptoms were assessed with the M.D. Anderson Symptom Inventory (MDASI). Key potential socio-demographic, biomedical, and physician-reported prognostic candidates were also considered. The Cox proportional hazards regression model was used for both univariate and multivariate analyses of survival. Additional sensitivity analysis, based on 500 bootstrap-generated simulation datasets, was also performed to confirm the results obtained with the Cox regression model. RESULTS: The median survival of the entire cohort was 4.8 months (range 0-28 months). The MDASI was completed at baseline by 91% of patients. The final multivariate model retained two parameters as independent prognostic factors for survival: clinical prognostic group and patient's self-reported severity of drowsiness. The following hazard ratios (HR) were found for curable vs. terminal: 0.055 (95% CI, 0.022-0.136; P < 0.001) and 0.193 (95% CI, 0.103-0.362: P < 0.001) for advanced vs. terminal. Patient's self-reported severity of drowsiness independently predicted survival with a HR of 1.801 (95% CI, 1.044-3.107; P = 0.033). Additional sensitivity analysis confirmed the independent prognostic value of variables identified in this study. CONCLUSION: The results suggest that patients' self-reporting of symptoms provides independent prognostic information for survival in patients with hematologic malignancies. These findings underscore the value of collecting patient-reported symptom data in routine clinical practice.
Authors: Loretta A Williams; Araceli G Garcia Gonzalez; Patricia Ault; Tito R Mendoza; Mary L Sailors; Janet L Williams; Furong Huang; Aziz Nazha; Hagop M Kantarjian; Charles S Cleeland; Jorge E Cortes Journal: Blood Date: 2013-06-18 Impact factor: 22.113
Authors: Andrea Tendas; Pasquale Niscola; Laura Scaramucci; Marco Giovannini; Teresa Dentamaro; Alessio Pio Perrotti; Paolo de Fabritiis Journal: Support Care Cancer Date: 2014-07-04 Impact factor: 3.603
Authors: Ashley Leak Bryant; AnnMarie Lee Walton; Julia Shaw-Kokot; Deborah K Mayer; Bryce B Reeve Journal: Oncol Nurs Forum Date: 2015-03 Impact factor: 2.172
Authors: Xing Wei; Hongfan Yu; Wei Dai; Wei Xu; Qingsong Yu; Yang Pu; Yaqin Wang; Jia Liao; Qiang Li; Qiuling Shi Journal: Support Care Cancer Date: 2021-08-27 Impact factor: 3.603
Authors: Pasquale Niscola; Andrea Tendas; Marco Giovannini; Laura Scaramucci; Alessio Perrotti; Paolo de Fabritiis; Debra A Howell Journal: Support Care Cancer Date: 2014-10-24 Impact factor: 3.603
Authors: Christina Ramsenthaler; Wei Gao; Richard J Siegert; Steve A Schey; Poly M Edmonds; Irene J Higginson Journal: Qual Life Res Date: 2017-07-27 Impact factor: 4.147
Authors: Ochaka J Egesie; Patricia A Agaba; Olugbenga A Silas; Chad Achenbach; Ayuba Zoakah; Oche O Agbaji; Jeremiah A Madaki; Edith N Okeke; Lifang Hou; Atiene S Sagay; Robert Murphy Journal: J Med Trop Date: 2018-05-29
Authors: Christina Ramsenthaler; Thomas R Osborne; Wei Gao; Richard J Siegert; Polly M Edmonds; Stephen A Schey; Irene J Higginson Journal: BMC Cancer Date: 2016-07-07 Impact factor: 4.430